Literature DB >> 11526512

An extracellular ligand increases the specific activity of the receptor-like protein tyrosine phosphatase DEP-1.

M Sörby1, J Sandström, A Ostman.   

Abstract

Cellular growth, differentiation and migration is regulated by protein tyrosine phosphorylation. Receptor-like protein tyrosine phosphatases are thus likely to be key regulators of vital cellular processes. The regulation of these enzymes is in general poorly understood. Ligands have been identified only for a small subset of the receptor-like protein tyrosine phosphatases and in no case has upregulation of the specific activity by extracellular ligands been demonstrated. Prompted by earlier findings of ligands for receptor-like protein tyrosine phosphatases in extracellular matrix we investigated if Matrigel, a preparation of extracellular matrix proteins, contained modulators of the specific activity of the receptor-like protein tyrosine phosphatase DEP-1. Matrigel stimulation of cells increased the specific activity of immunoprecipitated DEP-1. Also, incubation of immunoprecipitated DEP-1 with Matrigel led to an increase in DEP-1 activity, which was blocked by soluble DEP-1 extracellular domain. Finally, immunoprecipitated DeltaECD-DEP-1, a mutant form of DEP-1 lacking most of the extracellular domain, failed to respond to Matrigel stimulation. These experiments identify Matrigel as a source of DEP-1 agonist(s) and provide the first evidence for upregulation of the specific activity of receptor-like protein tyrosine phosphatases by extracellular ligands.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11526512     DOI: 10.1038/sj.onc.1204581

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Heparan sulfate proteoglycans are ligands for receptor protein tyrosine phosphatase sigma.

Authors:  A Radu Aricescu; Iain W McKinnell; Willi Halfter; Andrew W Stoker
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

2.  Preferential oxidation of the second phosphatase domain of receptor-like PTP-alpha revealed by an antibody against oxidized protein tyrosine phosphatases.

Authors:  Camilla Persson; Tobias Sjöblom; Arnoud Groen; Kai Kappert; Ulla Engström; Ulf Hellman; Carl-Henrik Heldin; Jeroen den Hertog; Arne Ostman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-04       Impact factor: 11.205

3.  Site-selective regulation of platelet-derived growth factor beta receptor tyrosine phosphorylation by T-cell protein tyrosine phosphatase.

Authors:  Camilla Persson; Catrine Sävenhed; Annie Bourdeau; Michel L Tremblay; Boyka Markova; Frank D Böhmer; Fawaz G Haj; Benjamin G Neel; Ari Elson; Carl-Henrik Heldin; Lars Rönnstrand; Arne Ostman; Carina Hellberg
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

Review 4.  Evaluating function of transmembrane protein tyrosine phosphatase CD148 in lymphocyte biology.

Authors:  Thomas R Harrod; Louis B Justement
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

5.  Receptor type protein tyrosine phosphatases (RPTPs) - roles in signal transduction and human disease.

Authors:  Yiru Xu; Gary J Fisher
Journal:  J Cell Commun Signal       Date:  2012-08-01       Impact factor: 5.782

6.  Density enhanced phosphatase-1 down-regulates urokinase receptor surface expression in confluent endothelial cells.

Authors:  Patrick M Brunner; Patricia C Heier; Judit Mihaly-Bison; Ute Priglinger; Bernd R Binder; Gerald W Prager
Journal:  Blood       Date:  2011-02-08       Impact factor: 22.113

7.  β-Integrin de-phosphorylation by the Density-Enhanced Phosphatase DEP-1 attenuates EGFR signaling in C. elegans.

Authors:  Michael Walser; Christoph Alois Umbricht; Erika Fröhli; Paolo Nanni; Alex Hajnal
Journal:  PLoS Genet       Date:  2017-01-30       Impact factor: 5.917

8.  Paladin is a phosphoinositide phosphatase regulating endosomal VEGFR2 signalling and angiogenesis.

Authors:  Anja Nitzsche; Riikka Pietilä; Dominic T Love; Chiara Testini; Takeshi Ninchoji; Ross O Smith; Elisabet Ekvärn; Jimmy Larsson; Francis P Roche; Isabel Egaña; Suvi Jauhiainen; Philipp Berger; Lena Claesson-Welsh; Mats Hellström
Journal:  EMBO Rep       Date:  2020-12-28       Impact factor: 8.807

9.  The tyrosine phosphatase CD148 is an essential positive regulator of platelet activation and thrombosis.

Authors:  Yotis A Senis; Michael G Tomlinson; Stuart Ellison; Alexandra Mazharian; Jenson Lim; Yan Zhao; Kristin N Kornerup; Jocelyn M Auger; Steve G Thomas; Tarvinder Dhanjal; Neena Kalia; Jing W Zhu; Arthur Weiss; Steve P Watson
Journal:  Blood       Date:  2009-02-25       Impact factor: 22.113

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.